Wills Hughes-Wilson
Corporate Officer/Principal bij MEREO BIOPHARMA GROUP PLC
Vermogen: 860 $ op 30-04-2024
Actieve functies van Wills Hughes-Wilson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MEREO BIOPHARMA GROUP PLC | Corporate Officer/Principal | 01-03-2018 | - |
Loopbaan van Wills Hughes-Wilson
Eerdere bekende functies van Wills Hughes-Wilson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Public Communications Contact | 04-07-2012 | 01-01-2018 |
Algemeen Adviseur | 01-02-2012 | 04-07-2012 | |
Corporate Officer/Principal | 01-02-2012 | 01-01-2018 | |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Directeur/Bestuurslid | - | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Opleiding van Wills Hughes-Wilson
University of Durham | Graduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Zweden | 2 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Public Communications Contact | 1 |
General Counsel | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
MEREO BIOPHARMA GROUP PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Wills Hughes-Wilson
- Ervaring